Strain sc|0025219


This strain is associated as type material for multiple names:

StrainInfo: SI-ID 92417 T

Taxon
Fusobacterium nucleatum subsp. nucleatum (not Fusobacterium nucleatumT)
Sample
Cervicofacial lesion
Cultures (12)
LMG 13131 = ATCC 25586 = CCUG 32989 = CCUG 33059 = CIP 101130 = JCM 8532 = CCRC 10681 = KCTC 2640 = DSM 15643 = BCRC 10681 = KCTC 5103 = ACM 3992
Other Designations (11)
Moore VPI 4355 = Prévot 1612A = LMG 13131T QC oorspr = LMG13131T QC 10/02 = LMG13131T QC 2/05 = LMG 13131T QC 12/99 = LMG13131T QC 5/05 = VPI4355 1612A = VPI 4355 = JCM 8522 = 1612A
Sequences (24)
  • Genome Assembly:GCA_031191795
    Fusobacterium nucleatum LMG 13131
  • rRNA Operon Nucleotide:AF342829
    Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:JQ724660
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone2 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • Gene Nucleotide:GQ275001
    Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 deoxyuridine 5'-triphosphate nucleotidohydrolase gene, partial cds
  • Gene Nucleotide:GQ274958
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 DNA-directed RNA polymerase beta chain (rpoB) gene, partial cds
  • rRNA Operon Nucleotide:JQ724661
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone4 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:JQ724667
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone15 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • Gene Nucleotide:X72582
    Fusobacterium nucleatum fomA gene, strain ATCC 25586
  • rRNA Operon Nucleotide:JQ724668
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone16 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:JQ724669
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone17 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • Gene Nucleotide:EU419254
    Fusobacterium nucleatum subsp. nucleatum RpoB (rpoB) gene, partial cds
  • rRNA Operon Nucleotide:JQ724662
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone5 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:GQ301038
    Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:AJ133496
    Fusobacterium nucleatum subsp. nucleatum 16S ribosomal RNA gene
  • rRNA Operon Nucleotide:JQ724663
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone7 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:JQ724666
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone14 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:JQ724665
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone13 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • rRNA Operon Nucleotide:M58683
    Fusobacterium nucleatum subsp. nucleatum small subunit ribosomal RNA gene sequence
  • rRNA Operon Nucleotide:JQ724664
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone8 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence
  • Gene Nucleotide:GQ275046
    Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 zinc protease gene, partial cds
  • Genome Assembly:GCA_000007325
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586
  • Genome Assembly:GCA_003019295 - Genome sc|0003277
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586
  • Genome Assembly:GCA_037900345
    Fusobacterium nucleatum subsp. nucleatum ATCC 25586
  • rRNA Operon Nucleotide:AB573068
    Fusobacterium nucleatum subsp. nucleatum gene for 16S ribosomal RNA, partial sequence, strain: JCM 8532
Associated Publications (73)
  • DOI: 10.1128/jb.152.1.201-207.1982
    Barker HA, Kahn JM, Hedrick L (1982). Pathway of lysine degradation in Fusobacterium nucleatum.
  • DOI: 10.1128/iai.57.2.656-659.1989
    Kato T, Takazoe I, Okuda K (1989). Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.
  • DOI: 10.1128/iai.55.3.771-777.1987
    Bird PS, Seymour GJ (1987). Production of monoclonal antibodies that recognize specific and cross-reactive antigens of Fusobacterium nucleatum.
  • DOI: 10.1128/iai.45.1.47-51.1984
    Naito Y, Okuda K, Takazoe I (1984). Immunoglobulin G response to subgingival gram-negative bacteria in human subjects.
  • DOI: 10.1111/j.1600-051x.1995.tb00798.x
    Horibe M, Watanabe H, Ishikawa I (1995). Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.
  • DOI: 10.1111/j.1399-302x.1996.tb00349.x
    Nunes IP, Jonsson R, Jensen HB, Bakken V (1996). Induction of systemic murine B-cell responses by Fusobacterium nucleatum and Porphyromonas gingivalis.
  • DOI: 10.1111/j.1399-302x.1997.tb00382.x
    George KS, Reynolds MA, Falkler WA Jr (1997). Arbitrarily primed polymerase chain reaction fingerprinting and clonal analysis of oral Fusobacterium nucleatum isolates.
  • D'Arcangelo C, Varvara G (1998). [A comparative in-vitro study of the bactericidal efficacy of sodium hypochlorite and chlorhexidine gluconate plus cetrimide on root canal anaerobic bacterial flora].
  • DOI: 10.1111/j.1348-0421.1999.tb02395.x
    Nagashima H, Takao A, Maeda N (1999). Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum.
  • DOI: 10.1034/j.1399-302x.2001.016003163.x
    Metzger Z, Featherstone LG, Ambrose WW, Trope M, Arnold RR (2001). Kinetics of coaggregation of Porphyromonas gingivalis with Fusobacterium nucleatum using an automated microtiter plate assay.
  • DOI: 10.1128/JB.184.7.2005-2018.2002
    Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D'Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek R (2002). Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586.
  • DOI: 10.1046/j.1365-2249.2002.01852.x
    Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJ (2002). Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
  • DOI: 10.1902/jop.2002.73.11.1260
    Liu CM, Shyu YC, Pei SC, Lan WH, Hou LT (2002). In vitro effect of laser irradiation on cementum-bound endotoxin isolated from periodontally diseased roots.
  • DOI: 10.1101/gr.566003
    Kapatral V, Ivanova N, Anderson I, Reznik G, Bhattacharyya A, Gardner WL, Mikhailova N, Lapidus A, Larsen N, D'Souza M, Walunas T, Haselkorn R, Overbeek R, Kyrpides N (2003). Genome analysis of F. nucleatum sub spp vincentii and its comparison with the genome of F. nucleatum ATCC 25586.
  • DOI: 10.1016/j.bbamem.2005.05.002
    Desvaux M, Khan A, Beatson SA, Scott-Tucker A, Henderson IR (2005). Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis.
  • DOI: 10.1128/JB.187.15.5330-5340.2005
    Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CX (2005). Identification and characterization of a novel adhesin unique to oral fusobacteria.
  • DOI: 10.1016/j.micpath.2005.07.002
    Silva VL, Diniz CG, Cara DC, Santos SG, Nicoli JR, Carvalho MA, Farias LM (2005). Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress.
  • Kim HS, Song SK, Yoo SY, Jin DC, Shin HS, Lim CK, Kim MS, Kim JS, Choe SJ, Kook JK (2005). Development of strain-specific PCR primers based on a DNA probe Fu12 for the identification of fusobacterium nucleatum subsp. nucleatum ATCC 25586T.
  • Bozza FL, Molgatini SL, Perez SB, Tejerina DP, Perez Tito RI, Kaplan AE (2005). Antimicrobial effect in vitro of chlorhexidine and calcium hydroxide impregnated gutta-percha points.
  • DOI: 10.1016/j.archoralbio.2006.05.002
    Sheng J, Nguyen PT, Baldeck JD, Olsson J, Marquis RE (2006). Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.
  • Thaweboon B, Thaweboon S, Choonharuangdej S, Suppakpatana P (2006). Effects of sonicated Prevotella intermedia, Fusobacterium nucleatum and Lactobacillus casei extracts on interleukin-8 production by human dental pulp cells.
  • DOI: 10.1111/j.1365-2672.2006.03236.x
    da Silva VL, Diniz CG, dos Santos SG, Gomes RM, Nicoli JR, Magalhaes PP, Mendes EN, de Carvalho MA, Farias LM (2007). Physiological alterations of a Fusobacterium nucleatum strain exposed to oxidative stress.
  • DOI: 10.1111/j.1399-302X.2008.00453.x
    Gursoy UK, Kononen E, Uitto VJ (2008). Stimulation of epithelial cell matrix metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria.
  • DOI: 10.1902/jop.2010.090664
    Gursoy UK, Pollanen M, Kononen E, Uitto VJ (2010). Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model.
  • DOI: 10.1099/mic.0.039180-0
    Yoshida Y, Ito S, Kamo M, Kezuka Y, Tamura H, Kunimatsu K, Kato H (2010). Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
  • DOI: 10.1128/AEM.00166-10
    Sasaki-Imamura T, Yano A, Yoshida Y (2010). Production of indole from L-tryptophan and effects of these compounds on biofilm formation by Fusobacterium nucleatum ATCC 25586.
  • DOI: 10.1074/jbc.M110.133140
    Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg A (2010). Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation.
  • DOI: 10.1099/mic.0.048934-0
    Yoshida Y, Suwabe K, Nagano K, Kezuka Y, Kato H, Yoshimura F (2011). Identification and enzymic analysis of a novel protein associated with production of hydrogen sulfide and L-serine from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
  • DOI: 10.1902/jop.2011.110177
    Gursoy UK, Pollanen M, Kononen E, Uitto VJ (2011). A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression.
  • DOI: 10.1099/mic.0.051813-0
    Suwabe K, Yoshida Y, Nagano K, Yoshimura F (2011). Identification of an L-methionine gamma-lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
  • DOI: 10.1016/j.anaerobe.2011.09.003
    Okuda T, Kokubu E, Kawana T, Saito A, Okuda K, Ishihara K (2011). Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.
  • DOI: 10.1155/2012/632796
    Basri DF, Tan LS, Shafiei Z, Zin NM (2011). In Vitro Antibacterial Activity of Galls of Quercus infectoria Olivier against Oral Pathogens.
  • DOI: 10.1902/jop.2012.120017
    Gursoy UK, Kononen E, Luukkonen N, Uitto VJ (2012). Human neutrophil defensins and their effect on epithelial cells.
  • DOI: 10.1099/ijs.0.041038-0
    Vartoukian SR, Downes J, Palmer RM, Wade WG (2012). Fretibacterium fastidiosum gen. nov., sp. nov., isolated from the human oral cavity.
  • DOI: 10.1016/j.anaerobe.2012.09.007
    de Souza Filho JA, Diniz CG, Barbosa NB, de Freitas MC, Lopes Neves MS, da Gama Mazzei RN, Gameiro J, Coelho CM, da Silva VL (2012). Morphological, biochemical, physiological and molecular aspects of the response of Fusobacterium nucleatum exposed to subinhibitory concentrations of antimicrobials.
  • DOI: 10.1155/2012/825362
    Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip J (2012). Antibacterial Activity of Myristica fragrans against Oral Pathogens.
  • DOI: 10.1007/s00784-013-0935-1
    Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Cirelli JA, Deschner J (2013). Regulation of visfatin by microbial and biomechanical signals in PDL cells.
  • DOI: 10.1007/s00784-013-1179-9
    Ciandrini E, Campana R, Federici S, Manti A, Battistelli M, Falcieri E, Papa S, Baffone W (2014). In vitro activity of Carvacrol against titanium-adherent oral biofilms and planktonic cultures.
  • DOI: 10.1155/2014/425421
    Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Rossa C Jr, Deschner J, Cirelli JA (2014). Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells.
  • DOI: 10.1016/j.anaerobe.2014.08.001
    Keskin M, Kononen E, Soderling E, Isik G, Firatli E, Uitto VJ, Gursoy UK (2014). Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.
  • DOI: 10.1371/journal.pone.0111329
    Doron L, Coppenhagen-Glazer S, Ibrahim Y, Eini A, Naor R, Rosen G, Bachrach G (2014). Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease.
  • DOI: 10.3892/ijmm.2014.1995
    Juiz PJ, Lucchese AM, Gambari R, Piva R, Penolazzi L, Di Ciano M, Uetanabaro AP, Silva F, Avila-Campos MJ (2014). Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis.
  • Majbauddin A, Kodani I, Ryoke K (2015). The Effect of Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin Solution on Growth and Volatile Sulfur Compounds Production of Oral Malodor Associated Some Anaerobic Periodontal Bacteria.
  • DOI: 10.1016/j.anaerobe.2016.02.008
    Musrati AA, Fteita D, Paranko J, Kononen E, Gursoy UK (2016). Morphological and functional adaptations of Fusobacterium nucleatum exposed to human neutrophil Peptide-1.
  • DOI: 10.1016/j.resmic.2016.03.004
    Manti A, Ciandrini E, Campana R, Dominici S, Ciacci C, Federici S, Sisti D, Rocchi MB, Papa S, Baffone W (2016). A dual-species microbial model for studying the dynamics between oral streptococci and periodontal pathogens during biofilm development on titanium surfaces by flow cytometry.
  • DOI: 10.1016/j.anaerobe.2016.04.017
    Bardaji DK, da Silva JJ, Bianchi TC, de Souza Eugenio D, de Oliveira PF, Leandro LF, Rogez HL, Venezianni RC, Ambrosio SR, Tavares DC, Bastos JK, Martins CH (2016). Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.
  • DOI: 10.1007/s00784-016-1960-7
    Stauffacher S, Lussi A, Nietzsche S, Neuhaus KW, Eick S (2016). Bacterial invasion into radicular dentine-an in vitro study.
  • DOI: 10.5808/GI.2016.14.4.255
    Habib AM, Islam MS, Sohel M, Mazumder MH, Sikder MO, Shahik SM (2016). Mining the Proteome of Fusobacterium nucleatum subsp. nucleatum ATCC 25586 for Potential Therapeutics Discovery: An In Silico Approach.
  • DOI: 10.1074/jbc.M117.819144
    Casasanta MA, Yoo CC, Smith HB, Duncan AJ, Cochrane K, Varano AC, Allen-Vercoe E, Slade DJ (2017). A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum.
  • DOI: 10.1042/BCJ20170838
    Kezuka Y, Ishida T, Yoshida Y, Nonaka T (2018). Structural insights into the catalytic mechanism of cysteine (hydroxyl) lyase from the hydrogen sulfide-producing oral pathogen, Fusobacterium nucleatum.
  • DOI: 10.1590/1678-7757-2017-0161
    Suzuki N, Nakano Y, Watanabe T, Yoneda M, Hirofuji T, Hanioka T (2018). Two mechanisms of oral malodor inhibition by zinc ions.
  • DOI: 10.1128/mSphere.00269-18
    Todd SM, Settlage RE, Lahmers KK, Slade DJ (2018). Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction.
  • DOI: 10.1155/2018/4147383
    Gamboa F, Munoz CC, Numpaque G, Sequeda-Castaneda LG, Gutierrez SJ, Tellez N (2018). Antimicrobial Activity of Piper marginatum Jacq and Ilex guayusa Loes on Microorganisms Associated with Periodontal Disease.
  • DOI: 10.1128/JB.00273-19
    Umana A, Sanders BE, Yoo CC, Casasanta MA, Udayasuryan B, Verbridge SS, Slade DJ (2019). Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.
  • DOI: 10.14744/nci.2019.05902
    Calik M, Calik SG, Dagli M, Kesli R, Esme H (2019). Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema.
  • DOI: 10.1016/j.archoralbio.2020.104744
    Tantivitayakul P, Kaypetch R, Muadchiengka T (2020). Thymoquinone inhibits biofilm formation and virulence properties of periodontal bacteria.
  • DOI: 10.4103/JCD.JCD_221_19
    Vankayala B, Anantula K, Saladi H, Gudugunta L, Basavarajaiah JM, Yadav SS (2020). Comparative evaluation of apical bacterial extrusion following root canal instrumentation using different endodontic file systems: An in vitro study.
  • DOI: 10.1021/acsinfecdis.0c00887
    Van Zuylen EM, Ferguson SA, Hughes A, Rennison D, Brimble MA, Cook GM (2021). Disruption of Metallostasis in the Anaerobic Human Pathogen Fusobacterium nucleatum by the Zinc Ionophore PBT2.
  • DOI: 10.1016/j.bbrc.2021.11.075
    Zhao T, Chen J, Liu S, Yang J, Wu J, Miao L, Sun W (2022). Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells.
  • DOI: 10.3389/fmicb.2022.798685
    Zhou J, Liu L, Wu P, Zhao L, Wu Y (2022). Fusobacterium nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism.
  • DOI: 10.5051/jpis.2104360218
    Liu M, Choi Y (2022). A murine periodontitis model using coaggregation between human pathogens and a predominant mouse oral commensal bacterium.
  • DOI: 10.1016/j.anaerobe.2022.102588
    Satokata AAC, Souza JH, Silva LLO, Santiago MB, Ramos SB, Assis LR, Theodoro RDS, Oliveira LRE, Regasini LO, Martins CHG (2022). Chalcones with potential antibacterial and antibiofilm activities against periodontopathogenic bacteria.
  • DOI: 10.3390/microorganisms10112200
    Karaca B, Haliscelik O, Gursoy M, Kiran F, Loimaranta V, Soderling E, Gursoy UK (2022). Analysis of Chemical Structure and Antibiofilm Properties of Exopolysaccharides from Lactiplantibacillus plantarum EIR/IF-1 Postbiotics.
  • DOI: 10.3390/pathogens12020201
    Wu X, Xu J, Yang X, Wang D, Xu X (2023). Integrating Transcriptomics and Metabolomics to Explore the Novel Pathway of Fusobacterium nucleatum Invading Colon Cancer Cells.
  • DOI: 10.4103/JAPTR.JAPTR_129_23
    Saputri D, Mubarak Z, Mudatsir M, Setyawati I, Setiawan AG, Abrar M (2023). Probing antibacterial drugs for Fusobacterium nucleatum subsp. nucleatum ATCC 25586 targeting UDP-N-acetylglucosamine 1-carboxyltransferase.
  • DOI: 10.1038/s41598-024-62846-x
    Zuraik AA, Daboul Y, Awama MA, Yazigi H, Kayasseh MA, Georges M (2024). Rapid detection of FadA in Fusobacterium nucleatum using the quantitative LAMP colorimetric phenol red method in stool samples from colorectal cancer patients.
  • DOI: 10.1021/acsinfecdis.4c00387
    Liu Z, Wang Y, Zhang C, Yang Y, Zhang J (2024). Engineering Short Antimicrobial Peptides to Specifically Target Fusobacterium nucleatum in the Mixed Microbial Population.
  • DOI: 10.1111/j.1348-0421.1996.tb01075.x
    Onoue S, Niwa M, Isshiki Y, Kawahara K (1996). Extraction and characterization of the smooth-type lipopolysaccharide from Fusobacterium nucleatum JCM 8532 and its biological activities.
  • DOI: 10.1111/j.1348-0421.2003.tb02785.x
    Onoue S, Imai T, Kumada H, Umemoto T, Kaca W, Isshiki Y, Kaneko A, Kawahara K (2003). Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
  • DOI: 10.1111/j.1574-6968.2008.01092.x
    Nagaoka S, Hojo K, Murata S, Mori T, Ohshima T, Maeda N (2008). Interactions between salivary Bifidobacterium adolescentis and other oral bacteria: in vitro coaggregation and coadhesion assays.
  • DOI: 10.1088/1752-7155/4/2/026005
    Ito S, Shimura S, Tanaka T, Yaegaki K (2010). Myrsinoic acid B inhibits the production of hydrogen sulfide by periodontal pathogens in vitro.
  • DOI: 10.3390/biomedicines8060160
    Kim K, Kim D, Lee H, Lee TH, Kim KY, Kim H (2020). New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.
  • DOI: 10.1080/19490976.2022.2100203
    Lawrence GW, McCarthy N, Walsh CJ, Kunyoshi TM, Lawton EM, O'Connor PM, Begley M, Cotter PD, Guinane CM (2022). Effect of a bacteriocin-producing Streptococcus salivarius on the pathogen Fusobacterium nucleatum in a model of the human distal colon.
Outside links and data sources
Retrieved 5 months ago via StrainInfo API (CC BY 4.0)

Genomics

Genomes (1)

Metadata

Cannonical URL
https://seqco.de/s:25219
Local history
  • Registered 11 months ago
  • Last modified 5 months ago
© 2022-2025 The SeqCode Initiative
  All information contributed to the SeqCode Registry is released under the terms of the Creative Commons Attribution (CC BY) 4.0 license